Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Consumer Studies Undermine Arguments for Medical Malpractice Tort Reform in Obamacare Replacement Bills

Center for Justice & Democracy
Posted on: 21 Nov 16

PR Newswire

NEW YORK, Nov. 21, 2016

NEW YORK, Nov. 21, 2016 /PRNewswire-USNewswire/ -- Americans for Insurance Reform (AIR), a project of the Center for Justice & Democracy representing a large coalition of public interest groups, today published two major new studies of the medical malpractice insurance industry. Stable Losses/Unstable Rates 2016 finds that medical malpractice premiums and claims per doctor are currently at their lowest level since data were first recorded four decades ago.  Premium Deceit 2016: The Failure of "Tort Reform to Cut Insurance Prices, finds that state limits on patients' legal rights have no impact whatsoever on insurance rates for doctors.

The studies can be found here: http://centerjd.org/content/new-med-mal-studies-americans-insurance-reform

These studies come at a critical time for health care in America, with new Congress and the President-elect both indicating they will push for repeal of the Affordable Care Act.  Medical malpractice "tort reform" proposals, which strip injured patients of their legal rights and undermine the authority of local juries, have been part of many ACA replacement bills.  They are also part of U.S. House Speaker Paul Ryan's published anti-Obamacare plan, which asserts that such measures are needed to reduce high insurance costs for doctors to keep them in practice.  The AIR studies show such arguments to be entirely baseless. 

Written by AIR co-founders J. Robert Hunter, Director of Insurance for the Consumer Federation of America, and Joanne Doroshow, Executive Director of the Center for Justice & Democracy, Stable Losses and Premium Deceit also demonstrate how the medical malpractice insurance industry manufactures liability insurance crises for America's doctors, price-gouging them with skyrocketing rates.

"Forty years of inflation-adjusted data show that medical malpractice claims and premiums are the lowest they have been in this entire period," said Hunter.  "The periodic premium spikes we saw in the data, such as in the mid-1970s, the mid-1980s and between 2002 and 2006, were not related to claims changes but to the economic cycle of insurers and to drops in investment income.  The last crisis ended a full decade ago and insurance rates for doctors have been dropping like a rock ever since.  This is true whether or not a state enacted severe medical malpractice tort restrictions. In fact, states that resisted adopting such harsh measures saw a greater drop in average medical malpractice insurance rates than states that passed them."

Doroshow added, "Federal medical malpractice proposals in ACA replacement bills, such as 'caps' on compensation for injured patients, are bad polices because they place incredibly cruel and unfair limits on the constitutional rights of everyday Americans.  Our studies show that such measures would do nothing to lower malpractice premiums for doctors, which are already at historic lows.  They will serve only to line the pockets of insurance companies, reduce the quality of our nation's healthcare, and increase the deficit as injured victims would be forced to turn to government health and disability programs for help."

Contact: Joanne Doroshow, 212 431 2853  joanned@centerjd.org

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/consumer-studies-undermine-arguments-for-medical-malpractice-tort-reform-in-obamacare-replacement-bills-300366790.html

SOURCE Center for Justice & Democracy

PR Newswire
www.prnewswire.com

Last updated on: 21/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.